253 related articles for article (PubMed ID: 24846808)
1. Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial.
Ferdinand KC; Elkayam U; Mancini D; Ofili E; Piña I; Anand I; Feldman AM; McNamara D; Leggett C
Am J Cardiol; 2014 Jul; 114(1):151-9. PubMed ID: 24846808
[TBL] [Abstract][Full Text] [Related]
2. A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination.
Cheng JW
Clin Ther; 2006 May; 28(5):666-78. PubMed ID: 16861089
[TBL] [Abstract][Full Text] [Related]
3. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure.
Ziaeian B; Fonarow GC; Heidenreich PA
JACC Heart Fail; 2017 Sep; 5(9):632-639. PubMed ID: 28711446
[TBL] [Abstract][Full Text] [Related]
4. BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients.
Carmody MS; Anderson JR
Cardiol Rev; 2007; 15(1):46-53. PubMed ID: 17172884
[TBL] [Abstract][Full Text] [Related]
5. Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.
Elkayam U; Bitar F
Am J Cardiol; 2005 Oct; 96(7B):37i-43i. PubMed ID: 16226934
[TBL] [Abstract][Full Text] [Related]
6. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
Golwala HB; Thadani U; Liang L; Stavrakis S; Butler J; Yancy CW; Bhatt DL; Hernandez AF; Fonarow GC
J Am Heart Assoc; 2013 Aug; 2(4):e000214. PubMed ID: 23966379
[TBL] [Abstract][Full Text] [Related]
7. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
Ghali JK; Tam SW; Ferdinand KC; Lindenfeld J; Sabolinski ML; Taylor AL; Worcel M; Curry CL; Cohn JN;
Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162
[TBL] [Abstract][Full Text] [Related]
8. Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure.
Thadani U; Jacob RG
Drugs Today (Barc); 2008 Dec; 44(12):925-37. PubMed ID: 19198701
[TBL] [Abstract][Full Text] [Related]
9. Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure.
Ofili E; Anand I; Williams RA; Akinboboye O; Xu L; Puckrein G
Adv Ther; 2017 Aug; 34(8):1976-1988. PubMed ID: 28707284
[TBL] [Abstract][Full Text] [Related]
10. The African-American Heart Failure Trial: background, rationale and significance.
Taylor AL; Cohn JN; Worcel M; Franciosa JA;
J Natl Med Assoc; 2002 Sep; 94(9):762-9. PubMed ID: 12392039
[TBL] [Abstract][Full Text] [Related]
11. The African American Heart Failure Trial: a clinical trial update.
Taylor AL
Am J Cardiol; 2005 Oct; 96(7B):44-8. PubMed ID: 16226935
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure.
Angus DC; Linde-Zwirble WT; Tam SW; Ghali JK; Sabolinski ML; Villagra VG; Winkelmayer WC; Worcel M;
Circulation; 2005 Dec; 112(24):3745-53. PubMed ID: 16344404
[TBL] [Abstract][Full Text] [Related]
13. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
Hammermeister KE; Fairclough D; Emsermann CB; Hamman R; Ho M; Phibbs S; Plomondon M; Valuck R; West D; Steiner JF
Clin Ther; 2009 Mar; 31(3):632-43. PubMed ID: 19393854
[TBL] [Abstract][Full Text] [Related]
15. Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure Trial.
Taylor AL; Ziesche S; Yancy CW; Carson P; Ferdinand K; Taylor M; Adams K; Olukotun AY; Ofili E; Tam SW; Sabolinski ML; Worcel M; Cohn JN;
Circulation; 2007 Apr; 115(13):1747-53. PubMed ID: 17372175
[TBL] [Abstract][Full Text] [Related]
16. Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.
Cohn JN; Tam SW; Anand IS; Taylor AL; Sabolinski ML; Worcel M;
J Card Fail; 2007 Jun; 13(5):331-9. PubMed ID: 17602978
[TBL] [Abstract][Full Text] [Related]
17. Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT).
Carson P; Johnson G; Fletcher R; Cohn J
J Am Coll Cardiol; 1996 Mar; 27(3):642-9. PubMed ID: 8606276
[TBL] [Abstract][Full Text] [Related]
18. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Loeb HS; Johnson G; Henrick A; Smith R; Wilson J; Cremo R; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
[TBL] [Abstract][Full Text] [Related]
19. Isosorbide dinitrate-hydralazine improves outcomes in African Americans with heart failure.
Colvin-Adams M; Taylor AL
Cleve Clin J Med; 2007 Mar; 74(3):227-34. PubMed ID: 17375804
[TBL] [Abstract][Full Text] [Related]
20. Effect of fixed-dose combination of isosorbide dinitrate and hydralazine on all hospitalizations and on 30-day readmission rates in patients with heart failure: results from the African-American Heart Failure Trial.
Anand IS; Win S; Rector TS; Cohn JN; Taylor AL
Circ Heart Fail; 2014 Sep; 7(5):759-65. PubMed ID: 24970468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]